AEON Biopharma

$AEON Biopharma(AEON)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001837607-25-000068  Act: 34  Size: 4 MB 网页链接

$AEON Biopharma(AEON)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001837607-25-000065  Act: 34  Size: 408 KB 网页链接

$AEON Biopharma(AEON)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001837607-25-000066  Act: 34  Size: 8 MB 网页链接

$AEON Biopharma(AEON)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002022308-25-000002  Act: 34  Size: 6 KB 网页链接

$AEON Biopharma(AEON)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-059840  Act: 33  Size: 17 KB 网页链接

$AEON Biopharma(AEON)$ 8-K Current report, item 5.07 Accession Number: 0001837607-25-000059  Act: 34  Size: 167 KB 网页链接

$AEON Biopharma(AEON)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-25-058531  Act: 34  Size: 356 KB 网页链接

$AEON Biopharma(AEON)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-25-058535  Act: 34  Size: 250 KB 网页链接

$AEON Biopharma(AEON)$ DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001104659-25-058336  Act: 34  Size: 59 KB 网页链接

$AEON Biopharma(AEON)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001137439-25-000540  Act: 34  Size: 6 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000141  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000134  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000135  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000136  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000137  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000129  Size: 4 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000130  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000131  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000132  Size: 5 KB 网页链接

$AEON Biopharma(AEON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000124  Size: 6 KB 网页链接